Tjallie van der Kooi

SUPPLEMENTARY DATA Appendix A: Patient characteristics for device assisted patients with a device‐associated infection and without an infection. Ventilated patients n = 1516 Patients with a CVC n = 1604 Patients with a urinary catheter n = 2259 no VAP VAP no CR‐BSI CR‐BSI no CA‐UTI CA‐UTI n % n % n % n % n % n % 1235 81.5 281 18.5 1549 96.6 55 3.4 2087 92.4 172 7.6 Male 773 62.9 201 71.8 989 64.1 32 58.2 1307 62.9 99 57.9 Age 0‐39 years 167 13.5 50 17.8 140 9.0 6 10.9 254 12.2 20 11.6 40‐69 years 534 43.2 135 48.0 704 45.4 28 50.9 946 45.3 88 51.2 70 years and older 534 43.2 196 34.2 705 45.5 21 38.2 887 42.5 64 37.2 APACHE II score 0‐9 173 14.0 30 10.7 314 20.3 8 14.6 422 20.2 31 18.0 10‐19 483 39.1 91 32.4 620 40.0 14 25.5 848 40.6 56 32.6 20‐29 368 29.8 117 41.6 424 27.4 27 49.1 543 26.0 56 32.6 30‐39 131 10.6 26 9.3 114 7.4 3 5.5 167 8.0 20 11.6 =>40 50 4.1 13 4.6 51 3.3 1 1.8 60 2.9 7 4.1 Unknown 30 2.4 4 1.4 26 1.7 2 3.6 47 2.3 2 1.2 Immunity nothing in particular 1137 92.1 263 93.9 1426 92.2 52 94.6 1953 93.7 152 88.4 leucopenia 7 5.7 0 0.0 13 0.8 1 1.8 14 0.7 0 0.0 otherwise immunocompromised 90 7.3 17 6.1 108 7.0 2 3.6 118 5.7 20 11.6 SDD use 204 16.5 37 13.2 161 10.4 10 18.2 221 10.6 23 13.4 34 Chapter 2

RkJQdWJsaXNoZXIy MTk4NDMw